As of 2024-07-27, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (16.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.05 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -636.5%.
The range of the Relative Valuation is (14.14) - (16.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 31.4x | 30.8x |
| Forward P/E multiples | 26.3x - 30.8x | 30.1x |
| Fair Price | (14.14) - (16.53) | (16.36) |
| Upside | -563.7% - -641.9% | -636.5% |
| Date | P/E |
| 2024-07-26 | -5.68 |
| 2024-07-25 | -5.77 |
| 2024-07-24 | -5.86 |
| 2024-07-23 | -5.90 |
| 2024-07-22 | -5.95 |
| 2024-07-19 | -6.05 |
| 2024-07-18 | -6.20 |
| 2024-07-17 | -6.51 |
| 2024-07-16 | -6.83 |
| 2024-07-15 | -6.16 |
| 2024-07-12 | -6.03 |
| 2024-07-11 | -6.16 |
| 2024-07-10 | -5.66 |
| 2024-07-09 | -5.46 |
| 2024-07-08 | -5.53 |
| 2024-07-05 | -5.34 |
| 2024-07-03 | -5.15 |
| 2024-07-02 | -5.10 |
| 2024-07-01 | -6.46 |
| 2024-06-28 | -6.51 |
| 2024-06-27 | -6.35 |
| 2024-06-26 | -6.20 |
| 2024-06-25 | -5.68 |
| 2024-06-24 | -5.92 |
| 2024-06-21 | -6.01 |
| 2024-06-20 | -6.12 |
| 2024-06-18 | -6.36 |
| 2024-06-17 | -6.00 |
| 2024-06-14 | -6.70 |
| 2024-06-13 | -6.76 |
| 2024-06-12 | -6.81 |
| 2024-06-11 | -6.77 |
| 2024-06-10 | -6.87 |
| 2024-06-07 | -6.70 |
| 2024-06-06 | -6.76 |
| 2024-06-05 | -7.11 |
| 2024-06-04 | -6.70 |
| 2024-06-03 | -7.18 |
| 2024-05-31 | -6.89 |
| 2024-05-30 | -6.42 |
| 2024-05-29 | -6.09 |
| 2024-05-28 | -6.35 |
| 2024-05-24 | -6.40 |
| 2024-05-23 | -6.46 |
| 2024-05-22 | -6.46 |
| 2024-05-21 | -6.40 |
| 2024-05-20 | -6.33 |
| 2024-05-17 | -5.95 |
| 2024-05-16 | -5.99 |
| 2024-05-15 | -5.58 |